Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunolo...
Leadership
Michael Thomas Henderson M.D.
CEO & Director
Jane Pritchett V. Henderson
Chief Financial Officer
Carl Linden Dambkowski M.D.
Chief Medical Officer
Noel Kurdi
Vice President of Investor Relations
Matthew Batters J.D.
Chief Legal Officer & Corporate Secretary
Emily Cox
SVP & Head of People
Rebecca Dabora Ph.D.
Chief Development Officer
Wendy Aspden-Curran
Senior Vice President of Clinical Operations
Drew Badger Ph.D.
Senior VP and Head of Regulatory Affairs & Toxicology
